CSIMarket Company Name, Ticker, Customers, else..
 
Eargo Inc   (NASDAQ: EAR)
Other Ticker:  
 
 
Price: $2.5700 $-0.11 -4.104%
Day's High: $2.64 Week Perf: -2.28 %
Day's Low: $ 2.56 30 Day Perf: -1.91 %
Volume (M): 201 52 Wk High: $ 0.00
Volume (M$): $ 517 52 Wk Avg: $0.00
Open: $2.62 52 Wk Low: $0.00



 Market Capitalization (Millions $) 53
 Shares Outstanding (Millions) 21
 Employees 145
 Revenues (TTM) (Millions $) 40
 Net Income (TTM) (Millions $) -108
 Cash Flow (TTM) (Millions $) -42
 Capital Exp. (TTM) (Millions $) 1

Eargo Inc
Eargo Inc is a medical technology company that is focused on developing and selling innovative hearing aids. Their hearing aids are designed to be sleek, comfortable, and virtually invisible, providing a discreet solution for individuals with hearing loss. Eargo's products utilize advanced technology to enhance sound quality and provide a personalized listening experience. The company prides itself on its direct-to-consumer model, which allows customers to purchase hearing aids online and receive ongoing remote support from licensed professionals. Eargo Inc aims to revolutionize the hearing aid industry by offering a convenient and user-friendly solution for individuals with hearing loss.


   Company Address: 2665 North First Street San Jose 95134 CA
   Company Phone Number: 351-7700   Stock Exchange / Ticker: NASDAQ EAR


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
EFSH   -43.84%    
• View Complete Report
   



Eargo Inc

Eargo Inc Faces Steep Losses as Demand Declines, Prompting Concern for Financial Outlook



Eargo Inc, a medical equipment and supplies company, has recently experienced a concerning deterioration in its business performance. Lower orders have resulted in vanishing revenue and amplified losses, as the company struggles to maintain its previous financial standing. This article aims to highlight the alarming downward trajectory of Eargo Inc's financials, comparing them to the Medical Equipment & Supplies sector and analyzing key indicators to gauge the potential impact on future demand.
Declining Revenue and Increased Losses
In the most recent fiscal period, Eargo Inc reported a substantial decline in revenue, with a staggering -7.271% drop to $7.33 million year on year. This decline not only highlights the struggling nature of the company's operations, but also showcases a clear disparity when compared to the revenue growth of the Medical Equipment & Supplies sector during the same period.
Eargo Inc

Eargo Inc Releases Q2 2023 Financial Results: Deficit per Share Climbs while Revenue Shows Modest Growth



Eargo Inc, a medical equipment and supplies company, recently released its financial results for the fiscal second quarter of 2023. The company experienced a significant increase in deficit per share compared to the previous year, but also achieved a modest growth in revenue. This article aims to interpret the financial results and provide an overview of the company's performance in the context of the medical equipment and supplies sector.
Financial Facts:
1. Deficit per Share: In Q2 2023, Eargo Inc reported a deficit per share of $-1.21, which was higher than the $-0.82 deficit per share recorded in the previous year's Q2. The deficit also grew from $-1.06 per share in the preceding reporting season.
Eargo Inc

Eargo Inc Reports Surge in Revenue, Signifying Strong Performance in Q1 20232.

Eargo Inc, a leading healthcare company, has recently announced some good news for its shareholders. The company?s ability to collect outstanding accounts receivable from its corporate clients has improved significantly, reaching a record high ratio of 9.26. This is a clear indication of improving liquidity for clients of Eargo Inc.
According to the company?s financial reports, the average receivable collection period for Eargo Inc in the March 31, 2023 quarter has decreased to 39 days, compared to 67 days in the December 31, 2022 quarter. The company?s overall receivables turnover ratio has also improved, with a total ranking of 103 so far, up from 136 in the fourth quarter of 2022.









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com